BioLineRx completes dose escalation stage of Phase I/II study for celiac disease drug

BioLineRx has completed the dose-escalation stage of the ongoing Phase I/II clinical study for BL-7010, a non-absorbable, orally available polymer intended for treatment of celiac disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news